Drug Research
Reviving Old Drugs with Specialty Intermediates in Europe
Drug development in the European pharmaceutical industry is undergoing a dramatic shift, largely due to the repurposing and reformulation of pre-existing chemicals rather than the...
Drug Research
Specialty Chemicals Solubility Enhances Drug Formulations
The need to improve the effectiveness, safety, and accessibility of drugs drives research and innovation in the ever-evolving pharmaceutical industry. The problem of solubility and...
Clinical Trials
Rina-S Shows Promise in Advanced Ovarian Cancer
Genmab has reported encouraging findings from the Phase 2 RAINFOL-01 trial of rinatabart sesutecan (Rina-S®), an experimental folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug combination (ADC). Data...
Drug Research
Revolutionizing Pharma Manufacturing with Biofermentation
Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing
Combining biofermentation with chemical synthesis is shown to be creative in the realm of pharmaceutical manufacturing. Following industry...
Drug Research
LINDIS Biotech Partners with Celonic for Production and Commercial...
LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it the only medicine licensed for the targeted and cancer-directed therapy of malignant ascites.
...
Drug Research
Thermo Fisher Launches Adolescent Alopecia Areata Registry
Thermo Fisher Scientific Inc., the global leader in serving science, has announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry. This initiative...
Drug Research
FDA Approves Roche’s Susvimo for Diabetic Macular Edema
Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL as the first and only continuous delivery...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.